Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report) has received an average rating of "Strong Buy" from the six research firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a buy recommendation and three have given a strong buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $16.50.
GTBIF has been the subject of several analyst reports. Ventum Cap Mkts upgraded shares of Green Thumb Industries to a "strong-buy" rating in a research report on Tuesday, August 6th. Roth Capital upgraded Green Thumb Industries to a "strong-buy" rating in a research note on Sunday. Finally, Craig Hallum upgraded Green Thumb Industries to a "strong-buy" rating in a research note on Monday, September 16th.
Get Our Latest Analysis on GTBIF
Green Thumb Industries Stock Up 14.7 %
Shares of OTCMKTS:GTBIF traded up $1.15 during midday trading on Tuesday, hitting $8.95. The stock had a trading volume of 893,041 shares, compared to its average volume of 464,708. The business's 50-day simple moving average is $10.26 and its 200-day simple moving average is $11.14. Green Thumb Industries has a 12 month low of $7.50 and a 12 month high of $16.33. The company has a market cap of $1.89 billion, a P/E ratio of 33.15 and a beta of 1.40.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The business had revenue of $286.87 million during the quarter, compared to analyst estimates of $283.96 million. As a group, equities analysts predict that Green Thumb Industries will post 0.32 earnings per share for the current year.
Green Thumb Industries Company Profile
(
Get Free ReportGreen Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Further Reading
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
